Mn(II) mediated degradation of artemisinin based on Fe3O4@MnSiO3-FA nanospheres for cancer therapy in vivo.
about
Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action.Magnetic and fluorescent carbon-based nanohybrids for multi-modal imaging and magnetic field/NIR light responsive drug carriers.Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy.Facile total synthesis of lysicamine and the anticancer activities of the RuII, RhIII, MnII and ZnII complexes of lysicamineAntitumor Research on Artemisinin and Its Bioactive Derivatives.
P2860
Mn(II) mediated degradation of artemisinin based on Fe3O4@MnSiO3-FA nanospheres for cancer therapy in vivo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Mn(II) mediated degradation of ...... es for cancer therapy in vivo.
@en
type
label
Mn(II) mediated degradation of ...... es for cancer therapy in vivo.
@en
prefLabel
Mn(II) mediated degradation of ...... es for cancer therapy in vivo.
@en
P2093
P2860
P356
P1433
P1476
Mn(II) mediated degradation of ...... es for cancer therapy in vivo.
@en
P2093
Haibao Wang
Jiajia Zhou
Pengping Xu
Qianwang Chen
Weijie Zhang
Zhenbang Liu
P2860
P304
12542-12551
P356
10.1039/C5NR02402A
P407
P577
2015-07-03T00:00:00Z